controlled-release morphine sulfate tablets ms contin (Shionogi)
90
Structured Review
Shionogi
controlled-release morphine sulfate tablets ms contin
Controlled Release Morphine Sulfate Tablets Ms Contin, supplied by Shionogi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/controlled-release+morphine+sulfate+tablets+ms+contin/controlled+release+morphine+sulfate+tablets+ms+contin/pm19466410-42-8-14
Average 90 stars, based on 1 article reviews
Controlled Release Morphine Sulfate Tablets Ms Contin, supplied by Shionogi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/controlled-release+morphine+sulfate+tablets+ms+contin/controlled+release+morphine+sulfate+tablets+ms+contin/pm19466410-42-8-14
Average 90 stars, based on 1 article reviews
controlled-release morphine sulfate tablets ms contin - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Article Snippet: Purpose To investigate the eVects of genetic polymorphisms on morphine-induced adverse events in cancer patients.. Methods We examined the relation of morphine-related adverse events to polymorphisms in UDP-glucuronosyltransferase (UGT) 2B7, ATP-binding cassette, sub-family B, number 1 (ABCB1), and -opioid receptor 1 genes in 32 Japanese cancer patients receiving oral controlled-release morphine sulfate tablets.. Results The T/T genotype at 1236 or TT/TT diplotype at 2677 and 3435 in ABCB1 was associated with signiWcantly lower frequency of fatigue (grades 1–3) (P = 0.012 or 0.011, Fisher’s exact test). |
